Association of Intraoperative Opioid Administration With Postoperative Pain and Opioid Use
JAMA Surgery · 01.08.2023 · 158 (8) · 854
DOI: 10.1001/jamasurg.2023.2009 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Surgery, erschienen am 01.08.2023. Verfasst von Laura A Santa Cruz Mercado und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston. Hauptthemen laut MEDLINE: Analgesics, Opioid, Opioid-Related Disorders. Die Arbeit wurde bisher 147-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIDA NIH HHS.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Importance Opioids administered to treat postsurgical pain are a major contributor to the opioid crisis, leading to chronic use in a considerable proportion of patients. Initiatives promoting opioid-free or opioid-sparing modalities of perioperative pain management have led to reduced opioid administration in the operating room, but this reduction could have unforeseen detrimental effects in terms of postoperative pain outcomes, as the relationship between intraoperative opioid usage and later opioid requirements is not well understood.
Objective
To characterize the association between intraoperative opioid usage and postoperative pain and opioid requirements. Design, Setting, and Participants This retrospective cohort study evaluated electronic health record data from a quaternary care academic medical center (Massachusetts General Hospital) for adult patients who underwent noncardiac surgery with general anesthesia from April 2016 to March 2020. Patients who underwent cesarean surgery, received regional anesthesia, received opioids other than fentanyl or hydromorphone, were admitted to the intensive care unit, or who died intraoperatively were excluded. Statistical models were fitted on the propensity weighted data set to characterize the effect of intraoperative opioid exposures on primary and secondary outcomes. Data were analyzed from December 2021 to October 2022. Exposures Intraoperative fentanyl and intraoperative hydromorphone average effect site concentration estimated using pharmacokinetic/pharmacodynamic models. Main Outcomes and Measures The primary study outcomes were the maximal pain score during the postanesthesia care unit (PACU) stay and the cumulative opioid dose, quantified in morphine milligram equivalents (MME), administered during the PACU stay. Medium- and long-term outcomes associated with pain and opioid dependence were also evaluated.
Results
The study cohort included a total of 61 249 individuals undergoing surgery (mean [SD] age, 55.44 [17.08] years; 32 778 [53.5%] female). Increased intraoperative fentanyl and intraoperative hydromorphone were both associated with reduced maximum pain scores in the PACU. Both exposures were also associated with a reduced probability and reduced total dosage of opioid administration in the PACU. In particular, increased fentanyl administration was associated with lower frequency of uncontrolled pain; a decrease in new chronic pain diagnoses reported at 3 months; fewer opioid prescriptions at 30, 90, and 180 days; and decreased new persistent opioid use, without significant increases in adverse effects. Conclusions and Relevance Contrary to prevailing trends, reduced opioid administration during surgery may have the unintended outcome of increasing postoperative pain and opioid consumption. Conversely, improvements in long-term outcomes might be achieved by optimizing opioid administration during surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston.
- Department of Anesthesia, Harvard Medical School, Boston, Massachusetts.
- Department of Anesthesia, Critical Care, and Pain Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
- Center for Perioperative Care, Department of Surgery, Massachusetts General Hospital, Boston.
Förderung
- NIGMS NIH HHS
- NIDA NIH HHS
Zitieren
APA
Santa Cruz Mercado, L. A., Liu, R., Bharadwaj, K. M., Johnson, J. J., Gutierrez, R., Das, P., Balanza, G., Deng, H., Pandit, A., Stone, T. A. D., Macdonald, T., Horgan, C., Tou, S. L. J., Houle, T. T., Bittner, E. A., & Purdon, P. L. (2023). Association of Intraoperative Opioid Administration With Postoperative Pain and Opioid Use. JAMA Surgery, 158(8), 854. https://doi.org/10.1001/jamasurg.2023.2009
Vancouver
Santa Cruz Mercado LA, Liu R, Bharadwaj KM, Johnson JJ, Gutierrez R, Das P, et al. Association of Intraoperative Opioid Administration With Postoperative Pain and Opioid Use. JAMA Surgery. 2023;158(8):854. doi:10.1001/jamasurg.2023.2009
BibTeX
@article{SantaCruzMercado2023,
author = {Santa Cruz Mercado, Laura A and Liu, Ran and Bharadwaj, Kishore M and Johnson, Jasmine J and Gutierrez, Rodrigo and Das, Proloy and Balanza, Gustavo and Deng, Hao and Pandit, Akriti and Stone, Tom A D and Macdonald, Teresa and Horgan, Caroline and Tou, Si Long Jenny and Houle, Timothy T and Bittner, Edward A and Purdon, Patrick L},
title = {Association of Intraoperative Opioid Administration With Postoperative Pain and Opioid Use},
journal = {JAMA Surgery},
year = {2023},
volume = {158},
number = {8},
pages = {854},
doi = {10.1001/jamasurg.2023.2009}
}
EUVIMED